Sep 11, 2023 / 02:00PM GMT
David Kenneth Rescott - Truist Securities, Inc., Research Division - Former Associate
Well, thank you guys, for coming. Really delighted today to be joined with the Axonics team. We have Co-Founder and CEO, Ray Cohen, and we have incoming CFO, Kari Keese. Before I get started, just some research disclosures. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
So getting started, Ray, curious how you're spending your time at the moment. It's been 10 years since co-founding Axonics. So keen to hear how the split of your time has shifted?
Questions and Answers:
Raymond W. Cohen - Axonics, Inc. - CEO & DirectorNow it's an interesting question. So I think the focus clearly is always on driving revenue. We've gone through the product development phase, the clinical studies and all that other